Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.42 EUR | -1.63% | -10.37% | +0.41% |
04-22 | BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment | MT |
04-11 | Gerresheimer shares down on outlook, but key contracts confirmed | RE |